Li-Lai Company is about to reach an agreement to acquire the psychedelic drug manufacturer Atai Beckley.

According to media reports citing informed sources, Eli Lilly is in negotiations to acquire the psychedelic drug manufacturer Atai Beckley, with the deal possibly being announced as early as this week. Atai Beckley's stock price surged 66% in after-hours trading, while Eli Lilly's stock price remained stable. Data shows that Atai Beckley has risen 31% year-to-date, with a market value of $1.97 billion as of the close of trading on Wednesday. The report stated that Eli Lilly is negotiating the deal with a premium.